ES2882806T5 - High protein nutritional compositions and using same - Google Patents

High protein nutritional compositions and using same

Info

Publication number
ES2882806T5
ES2882806T5 ES12701664T ES12701664T ES2882806T5 ES 2882806 T5 ES2882806 T5 ES 2882806T5 ES 12701664 T ES12701664 T ES 12701664T ES 12701664 T ES12701664 T ES 12701664T ES 2882806 T5 ES2882806 T5 ES 2882806T5
Authority
ES
Spain
Prior art keywords
protein
approximately
omega
nutritional composition
patient
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Active
Application number
ES12701664T
Other languages
English (en)
Spanish (es)
Other versions
ES2882806T3 (es
Inventor
Norman Alan Greenberg
Doug Bolster
Zamzam Kabiry Roughead (Fariba)
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Societe des Produits Nestle SA
Nestle SA
Original Assignee
Societe des Produits Nestle SA
Nestle SA
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=45554910&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=ES2882806(T5) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Societe des Produits Nestle SA, Nestle SA filed Critical Societe des Produits Nestle SA
Application granted granted Critical
Publication of ES2882806T3 publication Critical patent/ES2882806T3/es
Publication of ES2882806T5 publication Critical patent/ES2882806T5/es
Active legal-status Critical Current
Anticipated expiration legal-status Critical

Links

Classifications

    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23L—FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES, NOT OTHERWISE PROVIDED FOR; PREPARATION OR TREATMENT THEREOF
    • A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
    • A23L33/40—Complete food formulations for specific consumer groups or specific purposes, e.g. infant formula
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23L—FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES, NOT OTHERWISE PROVIDED FOR; PREPARATION OR TREATMENT THEREOF
    • A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
    • A23L33/10—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
    • A23L33/115—Fatty acids or derivatives thereof; Fats or oils
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23L—FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES, NOT OTHERWISE PROVIDED FOR; PREPARATION OR TREATMENT THEREOF
    • A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
    • A23L33/10—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
    • A23L33/17—Amino acids, peptides or proteins
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/02—Nutrients, e.g. vitamins, minerals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/04—Anorexiants; Antiobesity agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/06—Antihyperlipidemics

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Nutrition Science (AREA)
  • Polymers & Plastics (AREA)
  • Food Science & Technology (AREA)
  • Mycology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • General Chemical & Material Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Chemistry (AREA)
  • Pediatric Medicine (AREA)
  • Diabetes (AREA)
  • Obesity (AREA)
  • Hematology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Oil, Petroleum & Natural Gas (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Rheumatology (AREA)
  • Pain & Pain Management (AREA)
  • Child & Adolescent Psychology (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Coloring Foods And Improving Nutritive Qualities (AREA)
ES12701664T 2011-02-02 2012-01-26 High protein nutritional compositions and using same Active ES2882806T5 (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US201161438804P 2011-02-02 2011-02-02
PCT/US2012/022726 WO2012106179A1 (en) 2011-02-02 2012-01-26 High protein nutritional compositions and methods of making and using same

Publications (2)

Publication Number Publication Date
ES2882806T3 ES2882806T3 (es) 2021-12-02
ES2882806T5 true ES2882806T5 (en) 2026-03-13

Family

ID=45554910

Family Applications (1)

Application Number Title Priority Date Filing Date
ES12701664T Active ES2882806T5 (en) 2011-02-02 2012-01-26 High protein nutritional compositions and using same

Country Status (14)

Country Link
US (1) US9930908B2 (enExample)
EP (1) EP2670262B2 (enExample)
JP (1) JP6034805B2 (enExample)
CN (1) CN103347403B (enExample)
AU (3) AU2012212591A1 (enExample)
BR (1) BR112013019677B1 (enExample)
CA (1) CA2824591C (enExample)
ES (1) ES2882806T5 (enExample)
MX (1) MX2013009007A (enExample)
PH (1) PH12013501433A1 (enExample)
RU (1) RU2013140443A (enExample)
SG (1) SG191428A1 (enExample)
WO (1) WO2012106179A1 (enExample)
ZA (1) ZA201306543B (enExample)

Families Citing this family (13)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CA2824591C (en) 2011-02-02 2019-02-05 Nestec S.A. High protein nutritional compositions and methods of making and using same
AU2014225786B2 (en) 2013-03-08 2017-10-12 Axiom Foods, Inc. Rice protein supplements
EP3082465A2 (en) * 2013-12-19 2016-10-26 Abbott Laboratories Nutritional composition comprising hydrolyzed protein
CN105212042A (zh) * 2014-06-30 2016-01-06 罗汉斐 一种小麦发酵营养食品及其制作方法
CN110868870A (zh) 2017-05-12 2020-03-06 艾斯姆食品公司 大米产物及制备它们的系统和方法
US10806169B2 (en) 2018-05-15 2020-10-20 Kate Farms, Inc. Hydrolyzed pea protein-based nutrient composition
US12558370B2 (en) 2018-06-12 2026-02-24 Kate Farms, Inc. Intact pea protein-based nutrient composition
CN112367848A (zh) * 2018-06-14 2021-02-12 马斯公司 用于支持患有癌症的动物的组合物
US11058139B2 (en) * 2018-07-03 2021-07-13 Kerri Ann Langhorne Recovery supplement for horses
MX2021005925A (es) 2018-11-20 2021-06-30 Fonterra Cooperative Group Ltd Proceso y producto lacteo.
FR3093427B1 (fr) * 2019-03-05 2021-03-05 Mativa Tech Composition pour son utilisation dans la prévention et/ou le traitement de la dysbiose
JP2022534471A (ja) * 2019-05-31 2022-08-01 ソシエテ・デ・プロデュイ・ネスレ・エス・アー 動物における健康効果を提供するためのｍｃｔベースの栄養ブレンド
AR120346A1 (es) * 2019-10-31 2022-02-09 Idemitsu Kosan Co Agente para suprimir la resistencia a la insulina en rumiantes

Family Cites Families (21)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6140304A (en) * 1988-09-28 2000-10-31 Eicotech Corporation Method of and nutritional and pharmaceutical compositions for reduction of hyperinsulinemia
US5714472A (en) † 1993-12-23 1998-02-03 Nestec Ltd. Enternal formulation designed for optimized nutrient absorption and wound healing
DE69525150T2 (de) † 1994-04-01 2002-09-05 Abbott Laboratories, Abbott Park Nahrungsprodukt zur behandlung der ulzerativen kolitis sowie verwendung desselben
US5776913A (en) 1995-10-10 1998-07-07 Colgate Palmolive Company Therapeutic diet for metabolic abnormalities found in animals with lymphoma
CN1221249C (zh) * 1998-08-19 2005-10-05 斯凯伊药品加拿大公司 普鲁泊福的可注射水分散体
US20040121044A1 (en) * 2001-03-14 2004-06-24 John Tiano Nutritional product with high protein, low carbohydrate content and good physical stability
EP1383445A4 (en) * 2001-03-20 2005-04-13 Cydex Inc FORMULATIONS WITH PROPOFOL AND A SULFOALKYL ETHER CYCLODEXTRIN
SE526943C2 (sv) 2002-08-26 2005-11-22 Indevex Ab Födoämneskompositionsprodukt
US20040225022A1 (en) † 2003-05-09 2004-11-11 Desai Neil P. Propofol formulation containing reduced oil and surfactants
US20060280776A1 (en) * 2003-09-02 2006-12-14 Masafumi Koide Diet food
US7759507B2 (en) * 2003-09-05 2010-07-20 Abbott Laboratories Lipid system and methods of use
EP1723951A1 (en) † 2005-04-21 2006-11-22 N.V. Nutricia Nutritional supplement with oligosaccharides for a category of HIV patients
JP5667737B2 (ja) * 2004-07-01 2015-02-12 ネステク ソシエテ アノニム イヌ変形性関節症食餌製剤
JP5574561B2 (ja) * 2004-09-22 2014-08-20 味の素株式会社 総合経腸栄養組成物
CA2620366C (en) * 2005-08-26 2014-04-01 Nestec S.A. Nutrition for obese patients
US20070166411A1 (en) * 2005-12-16 2007-07-19 Bristol-Myers Squibb Company Nutritional supplement containing long-chain polyunsaturated fatty acids
EP1971230A2 (en) † 2006-01-09 2008-09-24 Nestec S.A. Treatment of stressed patients
JP5118125B2 (ja) * 2006-03-23 2013-01-16 ネステク ソシエテ アノニム 高カロリーの栄養補助食品
GB0612671D0 (en) * 2006-06-27 2006-08-09 Shs Int Ltd Nutritional formulation
PT2374452T (pt) † 2008-12-05 2019-10-31 Ajinomoto Kk Composição de nutrientes
CA2824591C (en) † 2011-02-02 2019-02-05 Nestec S.A. High protein nutritional compositions and methods of making and using same

Also Published As

Publication number Publication date
MX2013009007A (es) 2013-08-29
RU2013140443A (ru) 2015-03-10
CN103347403B (zh) 2016-04-20
CA2824591C (en) 2019-02-05
JP2014505702A (ja) 2014-03-06
BR112013019677A2 (pt) 2017-03-21
AU2016201327A1 (en) 2016-03-17
PH12013501433A1 (en) 2013-09-09
ES2882806T3 (es) 2021-12-02
JP6034805B2 (ja) 2016-11-30
US9930908B2 (en) 2018-04-03
EP2670262B1 (en) 2021-06-30
CA2824591A1 (en) 2012-08-09
ZA201306543B (en) 2015-03-25
BR112013019677B1 (pt) 2019-10-08
CN103347403A (zh) 2013-10-09
EP2670262A1 (en) 2013-12-11
US20140308390A1 (en) 2014-10-16
SG191428A1 (en) 2013-08-30
AU2012212591A1 (en) 2013-07-25
WO2012106179A1 (en) 2012-08-09
EP2670262B2 (en) 2025-10-15
AU2017225011B2 (en) 2019-07-18
AU2017225011A1 (en) 2017-09-28

Similar Documents

Publication Publication Date Title
ES2882806T3 (es) Composiciones nutricionales ricas en proteínas y métodos de fabricación y utilización de las mismas
JP5753850B2 (ja) 安定な増粘剤配合物
CN103025178B (zh) 用于从胃肠外营养转换至肠内营养的营养组合物和方法
US20140056862A1 (en) Nutritional compositions having alpha-hica and alpha-ketoglutarate
AU2012290065B2 (en) Vegetable-based nutritional products
CN102595936A (zh) 包含茶氨酸和外源性核苷酸的营养组合物